References – Loop Diuretic Use in Heart Failure

Feb 29, 2020 admin Uncategorized 0

References – Loop Diuretic Use in Heart Failure

Source Link HERE

  1. Rohde LE, Rover MM, Figueiredo Neto JA, et al. Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicenter, randomized trial. Eur Heart J 2019;40:3605-12.
  2. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Failure Association Task Force on Practice Guidelines. Circulation 2013;128:e240-327.
  3. Domanski M, Norman J, Pitt B, et al. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003;42:705-8.
  4. Ezekowitz JA, O’Meara E, McDonald MA, et al. 2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Can J Cardiol 2017;33:1342-433.
  5. Yancy CW, Januzzi JL Jr, Allen LA, et al. 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol 2018;71:201-30.
  6. Abraham B, Megaly M, Sous M, et al. Meta-analysis comparing torsemide versus furosemide in patients with heart failure. Am J Cardiol 2020;125:92-9.
  7. Kido K, Shimizu M, Hashiguchi M. Comparing torsemide versus furosemide in patients with heart failure: a meta-analysis. J Am Pharm Assoc 2019;59:432-8.
  8. Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019;21:137-55.
  9. Asrar ul Haq M, Wong C, Mutha V, et al. Therapeutic interventions in heart failure with preserved ejection fraction: a summary of current evidence. World J Cardiol 2014;6:67-76.
  10. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-200. [Erratum in Eur Heart J 2018;39:860].
  11. Colucci WS, Sterns RH. Use of diuretics in patients with heart failure. (Last updated November 14, 2019). In UpToDate, Post TW (ed), UpToDate, Waltham, MA 02013.
  12. Lorenz RA, Elwell RJ. Pre-dosing metolazone with loop diuretic combination regimens. Nephrol Nurs J 2006;33:78-9.
  13. Singh H, Marrs JC. Heart failure. In: Zeind CS, Carvalho MG, Eds. Applied Therapeutics: the Clinical Use of Drugs. 11th ed. Philadelphia, PA: Wolters Kluwer Health, 2018: 261-.305.
  14. Jackson EK. Drugs affecting renal excretory function. In: Brunton LL, Hilal-Dandan R, Knollmann BC, Eds. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 13th ed. New York, NY: McGraw-Hill, 2017: 445-70.

Cite this document as follows: Clinical Resource, Loop Diuretic Use in Heart Failure. Pharmacist’s Letter/Prescriber’s Letter. February 2020.

BÀI LIÊN QUAN